Camilla F. Olstad
Research Subjects
Camilla F. Olstad has a total of 20 co-authors. Here are the top co-authors by number of shared publications:
- Håkon Lund-Hanssen
Klinikk for bildediagnostikk, St. Olavs hospital
3 shared publications - Jan Franz Nygård
Cancer Registry of Norway, Oslo, Norway and UiT The Arctic University of Norway, Tromso, Norway
3 shared publications - Solveig Hofvind
Norwegian Institute of Public Health
3 shared publications - Solveig Roth Hoff
Department of Radiology, Division of Diagnostics, Møre og Romsdal Hospital Trust, Ålesund, Norway
3 shared publications Helene S. Solli
2 shared publications- Karl Øyvind Mikalsen
Department of Clinical Medicine, UiT The Arctic University of Norway, Tromsø, Norway
2 shared publications
Latest Publications
- 1 May 2024
- Published by Radiological Society of North America (RSNA) in Radiology: Artificial Intelligence
- Vol. 6 (3) , e230375
Performance of an Artificial Intelligence System for Breast Cancer Detection on Screening Mammograms from BreastScreen Norway
"Just Accepted" papers have undergone full peer review and have been accepted for publication in Radiology: Artificial Intelligence. This article will undergo copyediting, layout, and proof review before it is published in its final version. Please note that during production of the final copyedited article, errors may be discovered which could affect the content. Purpose To explore the standalone breast cancer detection performance at different risk score thresholds of a commercially available artificial intelligence (AI) system. Materials and Methods This retrospective study included information from 661,695 digital mammographic examinations performed among 242,629 female individuals screened as a part of x, 2004-2018. The study sample included 3807 screen-detected cancers (SDC) and 1110 interval breast cancers (IC). A continuous examination level risk score by the AI system was used to measure performance as the area under the receiver operating characteristic curve (AUC) with 95% CIs and cancer detection at different AI risk score thresholds. Results The AUC of the AI system was 0.93 (95% CI: 0.92-0.93) for SDC and IC combined and 0.97 (95% CI: 0.97-0.97) for SDC. In a setting where 10% of the examinations with the highest AI risk scores were defined as positive and 90% with the lowest scores as negative, 92.0% (3502/3807) of the SDC and 44.6% (495/1100) of the IC were identified by AI. In this scenario, 68.5% (10 987/16 029) of false positive screening results (negative recall assessment) were considered negative by AI. When 50% was used as the cut-off, 99.3% (3781/3807) of the SDC and 85.2% (946/1100) of the IC were identified as positive by AI, while 17.0% (2725/16 029) of the false positives were considered as negative. Conclusion The AI system showed high performance in detecting breast cancers within 2 years of screening mammography and a potential for triaging low-risk mammograms to reduce radiologist workload. ©RSNA, 2024.
- 1 May 2024
- Published by Radiological Society of North America (RSNA) in Radiology: Artificial Intelligence
- Vol. 6 (3) , e230375
Performance of an Artificial Intelligence System for Breast Cancer Detection on Screening Mammograms from BreastScreen Norway
"Just Accepted" papers have undergone full peer review and have been accepted for publication in Radiology: Artificial Intelligence. This article will undergo copyediting, layout, and proof review before it is published in its final version. Please note that during production of the final copyedited article, errors may be discovered which could affect the content. Purpose To explore the standalone breast cancer detection performance at different risk score thresholds of a commercially available artificial intelligence (AI) system. Materials and Methods This retrospective study included information from 661,695 digital mammographic examinations performed among 242,629 female individuals screened as a part of x, 2004-2018. The study sample included 3807 screen-detected cancers (SDC) and 1110 interval breast cancers (IC). A continuous examination level risk score by the AI system was used to measure performance as the area under the receiver operating characteristic curve (AUC) with 95% CIs and cancer detection at different AI risk score thresholds. Results The AUC of the AI system was 0.93 (95% CI: 0.92-0.93) for SDC and IC combined and 0.97 (95% CI: 0.97-0.97) for SDC. In a setting where 10% of the examinations with the highest AI risk scores were defined as positive and 90% with the lowest scores as negative, 92.0% (3502/3807) of the SDC and 44.6% (495/1100) of the IC were identified by AI. In this scenario, 68.5% (10 987/16 029) of false positive screening results (negative recall assessment) were considered negative by AI. When 50% was used as the cut-off, 99.3% (3781/3807) of the SDC and 85.2% (946/1100) of the IC were identified as positive by AI, while 17.0% (2725/16 029) of the false positives were considered as negative. Conclusion The AI system showed high performance in detecting breast cancers within 2 years of screening mammography and a potential for triaging low-risk mammograms to reduce radiologist workload. ©RSNA, 2024.
- 1 October 2023
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 309 (1) , e230989
AI Risk Score on Screening Mammograms Preceding Breast Cancer Diagnosis
Background Few studies have evaluated the role of artificial intelligence (AI) in prior screening mammography. Purpose To examine AI risk scores assigned to screening mammography in women who were later diagnosed with breast cancer. Materials and Methods Image data and screening information of examinations performed from January 2004 to December 2019 as part of BreastScreen Norway were used in this retrospective study. Prior screening examinations from women who were later diagnosed with cancer were assigned an AI risk score by a commercially available AI system (scores of 1-7, low risk of malignancy; 8-9, intermediate risk; and 10, high risk of malignancy). Mammographic features of the cancers based on the AI score were also assessed. The association between AI score and mammographic features was tested with a bivariate test. Results A total of 2787 prior screening examinations from 1602 women (mean age, 59 years ± 5.1 [SD]) with screen-detected (n = 1016) or interval (n = 586) cancers showed an AI risk score of 10 for 389 (38.3%) and 231 (39.4%) cancers, respectively, on the mammograms in the screening round prior to diagnosis. Among the screen-detected cancers with AI scores available two screening rounds (4 years) before diagnosis, 23.0% (122 of 531) had a score of 10. Mammographic features were associated with AI score for invasive screen-detected cancers (P < .001). Density with calcifications was registered for 13.6% (43 of 317) of screen-detected cases with a score of 10 and 4.6% (15 of 322) for those with a score of 1-7. Conclusion More than one in three cases of screen-detected and interval cancers had the highest AI risk score at prior screening, suggesting that the use of AI in mammography screening may lead to earlier detection of breast cancers. © RSNA, 2023 Supplemental material is available for this article. See also the editorial by Mehta in this issue.
- 1 October 2023
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 309 (1) , e230989
AI Risk Score on Screening Mammograms Preceding Breast Cancer Diagnosis
Background Few studies have evaluated the role of artificial intelligence (AI) in prior screening mammography. Purpose To examine AI risk scores assigned to screening mammography in women who were later diagnosed with breast cancer. Materials and Methods Image data and screening information of examinations performed from January 2004 to December 2019 as part of BreastScreen Norway were used in this retrospective study. Prior screening examinations from women who were later diagnosed with cancer were assigned an AI risk score by a commercially available AI system (scores of 1-7, low risk of malignancy; 8-9, intermediate risk; and 10, high risk of malignancy). Mammographic features of the cancers based on the AI score were also assessed. The association between AI score and mammographic features was tested with a bivariate test. Results A total of 2787 prior screening examinations from 1602 women (mean age, 59 years ± 5.1 [SD]) with screen-detected (n = 1016) or interval (n = 586) cancers showed an AI risk score of 10 for 389 (38.3%) and 231 (39.4%) cancers, respectively, on the mammograms in the screening round prior to diagnosis. Among the screen-detected cancers with AI scores available two screening rounds (4 years) before diagnosis, 23.0% (122 of 531) had a score of 10. Mammographic features were associated with AI score for invasive screen-detected cancers (P < .001). Density with calcifications was registered for 13.6% (43 of 317) of screen-detected cases with a score of 10 and 4.6% (15 of 322) for those with a score of 1-7. Conclusion More than one in three cases of screen-detected and interval cancers had the highest AI risk score at prior screening, suggesting that the use of AI in mammography screening may lead to earlier detection of breast cancers. © RSNA, 2023 Supplemental material is available for this article. See also the editorial by Mehta in this issue.
- 29 March 2022
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 303 (3) , 502-511
Artificial Intelligence Evaluation of 122 969 Mammography Examinations from a Population-based Screening Program
The performance of the artificial intelligence system was promising for breast cancer detection in a large population-based mammography screening program. Background Artificial intelligence (AI) has shown promising results for cancer detection with mammographic screening. However, evidence related to the use of AI in real screening settings remain sp...
- 29 March 2022
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 303 (3) , 502-511
Artificial Intelligence Evaluation of 122 969 Mammography Examinations from a Population-based Screening Program
The performance of the artificial intelligence system was promising for breast cancer detection in a large population-based mammography screening program. Background Artificial intelligence (AI) has shown promising results for cancer detection with mammographic screening. However, evidence related to the use of AI in real screening settings remain sp...